Older adult participation in cancer clinical trials: a systematic review of barriers and interventions

MS Sedrak, RA Freedman, HJ Cohen… - CA: a cancer journal …, 2021 - Wiley Online Library
Cancer is a disease of aging and, as the world's population ages, the number of older
persons with cancer is increasing and will make up a growing share of the oncology …

Primary PCI for myocardial infarction with ST-segment elevation

EC Keeley, LD Hillis - New England Journal of Medicine, 2007 - Mass Medical Soc
Foreword This Journal feature begins with a case vignette that includes a therapeutic
recommendation. A discussion of the clinical problem and the mechanism of benefit of this …

Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data

D Xavier, P Pais, PJ Devereaux, C Xie, D Prabhakaran… - The Lancet, 2008 - thelancet.com
Background India has the highest burden of acute coronary syndromes in the world, yet little
is known about the treatments and outcomes of these diseases. We aimed to document the …

Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction …

CM Gibson, YB Pride, PD Frederick, CV Pollack Jr… - American heart …, 2008 - Elsevier
BACKGROUND: Among patients with ST-segment elevation myocardial infarction (STEMI),
rapid reperfusion is associated with improved mortality. As such, door-to-needle (D2N) and …

Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice

A Diwan, M Krenz, FM Syed… - The Journal of …, 2007 - Am Soc Clin Investig
Following myocardial infarction, nonischemic myocyte death results in infarct expansion,
myocardial loss, and ventricular dysfunction. Here, we demonstrate that a specific …

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials

AB Kornblith, M Kemeny, BL Peterson, J Wheeler… - Cancer, 2002 - Wiley Online Library
BACKGROUND Prior research has documented the under‐representation in clinical trials of
older patients with cancer. In part of a larger study to test the magnitude of these barriers to …

[HTML][HTML] Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium

DI Bromage, SM Davidson, DM Yellon - Pharmacology & therapeutics, 2014 - Elsevier
Alleviating myocardial injury associated with ST elevation myocardial infarction is central to
improving the global burden of coronary heart disease. The chemokine stromal cell-derived …

Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks

IC Rokos, DM Larson, TD Henry, WJ Koenig… - American heart …, 2006 - Elsevier
Recent developments have provided a unique opportunity for the organization of regional
ST-elevation myocardial infarction (STEMI) receiving center (SRC) networks. Because …

Usefulness of mean platelet volume-to-lymphocyte ratio for predicting angiographic no-reflow and short-term prognosis after primary percutaneous coronary …

A Kurtul, SK Acikgoz - The American journal of cardiology, 2017 - Elsevier
Primary percutaneous coronary intervention (pPCI) is associated with improved prognosis in
patients with ST-segment elevation myocardial infarction (STEMI). However, no-reflow …

Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

DI Bromage, TR Godec, M Pujades-Rodriguez… - Cardiovascular …, 2019 - Springer
Background The use of metformin after acute myocardial infarction (AMI) has been
associated with reduced mortality in people with type 2 diabetes mellitus (T2DM). However …